ATLAS IRON Ltd/ADR (OTCMKTS: RHHBY) and Roche Holdings AG Basel ADR Common Stock (OTCMKTS:RHHBY) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.
Insider and Institutional Ownership
0.6% of Roche Holdings AG Basel ADR Common Stock shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This is a summary of recent ratings for ATLAS IRON Ltd/ADR and Roche Holdings AG Basel ADR Common Stock, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|ATLAS IRON Ltd/ADR||0||0||0||0||N/A|
|Roche Holdings AG Basel ADR Common Stock||4||3||3||0||1.90|
Roche Holdings AG Basel ADR Common Stock has a consensus target price of $34.00, suggesting a potential upside of 11.18%. Given Roche Holdings AG Basel ADR Common Stock’s higher probable upside, analysts clearly believe Roche Holdings AG Basel ADR Common Stock is more favorable than ATLAS IRON Ltd/ADR.
Earnings and Valuation
This table compares ATLAS IRON Ltd/ADR and Roche Holdings AG Basel ADR Common Stock’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|ATLAS IRON Ltd/ADR||$656.46 million||1.26||$36.16 million||N/A||N/A|
|Roche Holdings AG Basel ADR Common Stock||$54.15 billion||3.85||$8.77 billion||$1.95||15.68|
Roche Holdings AG Basel ADR Common Stock has higher revenue and earnings than ATLAS IRON Ltd/ADR.
Roche Holdings AG Basel ADR Common Stock pays an annual dividend of $0.89 per share and has a dividend yield of 2.9%. ATLAS IRON Ltd/ADR does not pay a dividend. Roche Holdings AG Basel ADR Common Stock pays out 45.6% of its earnings in the form of a dividend.
This table compares ATLAS IRON Ltd/ADR and Roche Holdings AG Basel ADR Common Stock’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|ATLAS IRON Ltd/ADR||N/A||N/A||N/A|
|Roche Holdings AG Basel ADR Common Stock||N/A||N/A||N/A|
Risk and Volatility
ATLAS IRON Ltd/ADR has a beta of 14, suggesting that its stock price is 1,300% more volatile than the S&P 500. Comparatively, Roche Holdings AG Basel ADR Common Stock has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.
Roche Holdings AG Basel ADR Common Stock beats ATLAS IRON Ltd/ADR on 7 of the 9 factors compared between the two stocks.
About ATLAS IRON Ltd/ADR
Atlas Iron Limited, an independent iron ore company, explores for, develops, mines, and sells iron ore in the Pilbara region in Western Australia. Its primary projects include Abydos and Mt Webber mines. The company is based in Perth, Australia.
About Roche Holdings AG Basel ADR Common Stock
Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, liver, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases. The company provides diagnostic solutions, such as blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring; diabetes therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogeneous immuno assays; immunology; infectious diseases; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control service; real-time PCR diagnostic systems; serum work area; urinalysis; and workflow solutions. Roche Holding AG has a strategic alliance with Wisconsin Diagnostic Laboratories; and a collaboration agreement with Five Prime Therapeutics, Inc. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Receive News & Ratings for ATLAS IRON Ltd/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ATLAS IRON Ltd/ADR and related companies with MarketBeat.com's FREE daily email newsletter.